Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2025 Earnings Call Transcript May 6, 2025
Jazz Pharmaceuticals plc misses on earnings expectations. Reported EPS is $1.68 EPS, expectations were $4.51.
Operator: Hello and thank you for standing by. My name is Tiffany, and I will be your conference operator today. At this time, I would like to welcome everyone to the Jazz Pharmaceuticals First Quarter 2025 Webcast Conference Call. All lines have been placed on mute to prevent any background noise....
